Sponsor Pipeline

Alebund Pharmaceuticals Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
2
Active Trials
2
Recruiting
1
Phase 3
1
Disease Areas
Active Trials by Phase
Phase 3
1
Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT06933472 A Study of a Novel Iron-based Phosphate Binder AP301 in Patients With Hyperphosphatemia… Hyperphosphatemia Recruiting
Phase 1
NCT06666283 A Study to Evaluate the Safety, Tolerability, PK and PD of AP303 in DKD Patients Diabetic Kidney Disease Recruiting
Disease Areas
Chronic Kidney Disease (2)
Get alerts when Alebund Pharmaceuticals's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free